As shown in Fig. 1a, a significantly increased level of YY1 was seen in patients with melanoma (primary and metastatic melanomas), compared with the levels detected in age/gender-matched controls with benign nevi (p < 0.01) and normal tissue controls (p < 0.001). The gene discussed is YY1; the disease is metastatic melanoma.